A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer.
Mitin N, Nyrop KA, Strum SL, Knecht A, Carey LA, Reeder-Hayes KE, Claire Dees E, Jolly TA, Kimmick GG, Karuturi MS, Reinbolt RE, Speca JC, O'Hare EA, Muss HB.
Mitin N, et al. Among authors: strum sl.
NPJ Breast Cancer. 2022 Sep 8;8(1):103. doi: 10.1038/s41523-022-00473-3.
NPJ Breast Cancer. 2022.
PMID: 36075910
Free PMC article.